Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers
- PMID: 33902786
- PMCID: PMC8314060
- DOI: 10.1017/S0950268821000984
Prevalence of antibodies to SARS-CoV-2 in Irish hospital healthcare workers
Abstract
Hospital healthcare workers (HCWs) are at increased risk of contracting COVID-19 infection. We aimed to determine the seroprevalence of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies in HCWs in Ireland. Two tertiary referral hospitals in Irish cities with diverging community incidence and seroprevalence were identified; COVID-19 had been diagnosed in 10.2% and 1.8% of staff respectively by the time of the study (October 2020). All staff of both hospitals (N = 9038) were invited to participate in an online questionnaire and blood sampling for SARS-CoV-2 antibody testing. Frequencies and percentages for positive SARS-CoV-2 antibody were calculated and adjusted relative risks (aRR) for participant characteristics were calculated using multivariable regression analysis. In total, 5788 HCWs participated (64% response rate). Seroprevalence of antibodies to SARS-CoV-2 was 15% and 4.1% in hospitals 1 and 2, respectively. Thirty-nine percent of infections were previously undiagnosed. Risk for seropositivity was higher for healthcare assistants (aRR 2.0, 95% confidence interval (CI) 1.4-3.0), nurses (aRR: 1.6, 95% CI 1.1-2.2), daily exposure to patients with COVID-19 (aRR: 1.6, 95% CI 1.2-2.1), age 18-29 years (aRR: 1.4, 95% CI 1.1-1.9), living with other HCWs (aRR: 1.3, 95% CI 1.1-1.5), Asian background (aRR: 1.3, 95% CI 1.0-1.6) and male sex (aRR: 1.2, 95% CI 1.0-1.4). The HCW seroprevalence was six times higher than community seroprevalence. Risk was higher for those with close patient contact. The proportion of undiagnosed infections call for robust infection control guidance, easy access to testing and consideration of screening in asymptomatic HCWs. With emerging evidence of reduction in transmission from vaccinated individuals, the authors strongly endorse rapid vaccination of all HCWs.
Keywords: COVID-19; Coronavirus; SARS-CoV-2 antibodies; healthcare workers; seroprevalence.
Conflict of interest statement
None of the authors have any conflicts of interest to declare.
Figures
Similar articles
-
Prevalence of Antibodies to SARS-CoV-2 Following Natural Infection and Vaccination in Irish Hospital Healthcare Workers: Changing Epidemiology as the Pandemic Progresses.Front Med (Lausanne). 2022 Feb 4;8:758118. doi: 10.3389/fmed.2021.758118. eCollection 2021. Front Med (Lausanne). 2022. PMID: 35186963 Free PMC article.
-
Seroprevalence of anti-SARS-CoV-2 IgG antibodies pre- and post-COVID-19 vaccination in staff members of Bandar Abbas Children's Hospital.BMC Infect Dis. 2024 Feb 23;24(1):253. doi: 10.1186/s12879-023-08863-z. BMC Infect Dis. 2024. PMID: 38395759 Free PMC article.
-
Cross-sectional prevalence of SARS-CoV-2 antibodies in healthcare workers in paediatric facilities in eight countries.J Hosp Infect. 2021 Apr;110:60-66. doi: 10.1016/j.jhin.2020.12.019. Epub 2021 Jan 7. J Hosp Infect. 2021. PMID: 33422589 Free PMC article.
-
Seroprevalence of SARS-CoV-2 antibodies and associated factors in healthcare workers: a systematic review and meta-analysis.J Hosp Infect. 2021 Feb;108:120-134. doi: 10.1016/j.jhin.2020.11.008. Epub 2020 Nov 16. J Hosp Infect. 2021. PMID: 33212126 Free PMC article.
-
The seroprevalence of SARS-CoV-2 antibodies among health care workers before the era of vaccination: a systematic review and meta-analysis.Clin Microbiol Infect. 2021 Sep;27(9):1242-1249. doi: 10.1016/j.cmi.2021.05.036. Epub 2021 Jun 8. Clin Microbiol Infect. 2021. PMID: 34116205 Free PMC article.
Cited by
-
Potential Application of SARS-CoV-2 Rapid Antigen Diagnostic Tests for the Detection of Infectious Individuals Attending Mass Gatherings - A Simulation Study.Front Epidemiol. 2022 Apr 25;2:862826. doi: 10.3389/fepid.2022.862826. eCollection 2022. Front Epidemiol. 2022. PMID: 38455312 Free PMC article.
-
Assessment of early and post COVID-19 vaccination antibody response in healthcare workers: a multicentre cross-sectional study on inactivated, mRNA and vector-based vaccines.Epidemiol Infect. 2023 Jan 5;151:e12. doi: 10.1017/S0950268822001984. Epidemiol Infect. 2023. PMID: 36688340 Free PMC article.
-
The COVID-19 Pandemic and Health and Care Workers: Findings From a Systematic Review and Meta-Analysis (2020-2021).Int J Public Health. 2023 Mar 3;68:1605421. doi: 10.3389/ijph.2023.1605421. eCollection 2023. Int J Public Health. 2023. PMID: 36938301 Free PMC article.
-
Neutralising antibodies against SARS-CoV-2 give important information on Covid-19 epidemic evolution in Rabat, Morocco, March 2020-February 2021.Afr Health Sci. 2023 Sep;23(3):400-405. doi: 10.4314/ahs.v23i3.46. Afr Health Sci. 2023. PMID: 38357173 Free PMC article.
-
SARS-CoV-2 epidemiology, antibody dynamics, and neutralisation capacity in Irish healthcare workers in the era of booster COVID-19 vaccinations.Front Med (Lausanne). 2023 Jan 26;10:1078022. doi: 10.3389/fmed.2023.1078022. eCollection 2023. Front Med (Lausanne). 2023. PMID: 36778745 Free PMC article.
References
-
- Karlsson U and Fraenkel C-J (2020) COVID-19: risks to healthcare workers and their families. British Medical Journal 371, m3944. - PubMed
-
- Richterman A, Meyerowitz EA and Cevik M (2020) Hospital-acquired SARS-CoV-2 infection: lessons for public health. Journal of the American Medical Association 324, 2155. - PubMed
-
- Watson J, Richter A and Deeks J (2020) Testing for SARS-CoV-2 antibodies. British Medical Journal 370, m3325. - PubMed
-
- HPSC COVID-19 in Healthcare Workers [Internet] (2021) HPSC COVID-19 in Healthcare Workers. Available at https://www.hpsc.ie/a-z/respiratory/coronavirus/novelcoronavirus/surveil...
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous